Citation Impact

Citing Papers

Review of Acute and Chronic Pain Published Studies
1996
Methodological and Ethical Issues in Clinical Trials of Acupuncture
1998
Fundamentals and advances in magnesium alloy corrosion
2017 Standout
A Genetic Polymorphism (rs17251221) in the Calcium-Sensing Receptor Gene (CASR) Is Associated with Stone Multiplicity in Calcium Nephrolithiasis
2011
The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway
2019
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
2006
Green tea and tea polyphenols in cancer prevention
2004
Kidney stones: pathophysiology and medical management
2006 Standout
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
2009 Standout
AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide
2003
Xenoestrogens at Picomolar to Nanomolar Concentrations Trigger Membrane Estrogen Receptor-α–Mediated Ca 2+ Fluxes and Prolactin Release in GH3/B6 Pituitary Tumor Cells
2005
p53 polymorphisms: cancer implications
2009
The Role of Tea in Human Health: An Update
2002
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
2008 StandoutNobel
In vitro Cytotoxicity of Epigallocatechin Gallate and Tea Extracts to Cancerous and Normal Cells from the Human Oral Cavity
2004
Evaluation of hypoxia‐inducible factor 1α overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma
2005
The green tea compound, (−)‐epigallocatechin‐3‐gallate downregulates N‐cadherin and suppresses migration of bladder carcinoma cells
2007
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?
2016 Standout
A Thought on the Biological Activities of Black Tea
2009
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle
2004
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Molecular Aspects of Bladder Cancer
2002
Single-nucleotide Polymorphisms in the p53 Signaling Pathway
2009
Targeting of cancer energy metabolism
2009
Humoral Hypercalcaemia in Renal Carcinoma due to Parathyroid Hormone Related Protein
1993
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Biochemistry and pharmacology of endovanilloids
2007
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
The p38 transduction pathway in prostatic neoplasia
2005
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
2009 Standout
p53 in health and disease
2007 Standout
Chlovalicin, a New Cytocidal Antibiotic Produced by Sporothrix sp. FO-4649. I Taxonomy, Fermentation, Isolation and Biological Activities.
1996 StandoutNobel
Multi-targeted therapy of cancer by genistein
2008 Standout
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
2006 Standout
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
Polymorphisms in the p53 pathway
2006
Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications
2006 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Epidemiology of stone disease across the world
2017 Standout
The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention
2010 Standout
Catechins Induce Oxidative Damage to Cellular and Isolated DNA through the Generation of Reactive Oxygen Species
2003
Exposure to lanthanum compound diminishes LPS-induced inflammation-associated gene expression: involvements of PKC and NF-κB signaling pathways
2010
Acute Renal Colic from Ureteral Calculus
2004
Renal cell carcinoma
2017 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
The first 30 years of p53: growing ever more complex
2009 Standout
Evaluation for Safety of Antioxidant Chemopreventive Agents
2005
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
2010 Standout
Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile Molecule
2012 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
Prevalence of symptomatic urinary calculi in Kerman, Iran.
2008
Carcinoma in a Bladder Diverticulum: Presentation and Treatment Outcome
2003
Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Risk of Advanced Prostate Cancer
2005
Acupuncture: Theory, Efficacy, and Practice
2002 Standout
A luminescent ruthenium(ii) complex for light-triggered drug release and live cell imaging
2015
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.
2002
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Soy Phytochemicals Prevent Orthotopic Growth and Metastasis of Bladder Cancer in Mice by Alterations of Cancer Cell Proliferation and Apoptosis and Tumor Angiogenesis
2006
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials
2017 Standout
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment
2005 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
X-Ray Diffraction Crystallography
2011
A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer
2007
Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice.
1995
Renal stone disease in Christchurch, New Zealand. Part 1: presentation and epidemiology.
2009
Model Study of the Enzymatic Modification of Natural Extracts: Peroxidase-Based Removal of Eugenol from Rose Essential Oil
2011
Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate
2006 Standout
Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption
2009 Standout
ELEVATED TISSUE EXPRESSION OF HYALURONIC ACID AND HYALURONIDASE VALIDATES THE HA-HAase URINE TEST FOR BLADDER CANCER
2001
n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems
2008 StandoutNobel
Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate
2004
Regulation of angiogenesis by hypoxia-inducible factor 1
2006 StandoutNobel
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Kidney stones: a global picture of prevalence, incidence, and associated risk factors.
2010 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout

Works of Jong‐Khing Huang being referenced

Epidemiological Studies on the Prevalence of Upper Urinary Calculi in Taiwan
2002
Effect of olvanil (N-vanillyl-cis-9-octadecenoamide) on cytosolic Ca2+ increase in renal tubular cells
2002
Mechanism of estrogens‐induced increases in intracellular Ca2+ in PC3 human prostate cancer cells
2001
Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells
2006
Mechanisms of AM404-induced [Ca2+]i rise and death in human osteosarcoma cells
2008
Tea consumption: fluid intake and bladder cancer risk in southern Taiwan
1999
AM-404 elevates renal intracellular Ca2+, questioning its selectivity as a pharmacological tool for investigating the anandamide transporter
2001
Effect of Thymol on Ca<sup>2+</sup> Homeostasis and Viability in MG63 Human Osteosarcoma Cells
2011
Effect of clomiphene on Ca2+ movement in human prostate cancer cells
2002
Intradiverticular Tumors of the Bladder: Surgical Implications - An Eleven-Year Review
1993
Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population
2004
EFFECTS OF ECONAZOLE ON Ca2+ LEVELS IN AND THE GROWTH OF HUMAN PROSTATE CANCER PC3 CELLS
2005
Capsazepine elevates intracellular Ca2+ in human osteosarcoma cells, questioning its selectivity as a vanilloid receptor antagonist
2004
p53Codon 72 andp21Codon 31 Polymorphisms in Prostate Cancer
2004
The carcinogen safrole increases intracellular free Ca2+ levels and causes death in MDCK cells.
2007
Acupuncture in the Treatment of Renal Colic
1992
The Incidence and Prognostic Significance of Humoral Hypercalcemia in Renal Cell Carcinoma
1991
The Role of p53, bcl-2 and E-Cadherin Expression in Predicting Biochemical Relapse for Organ Confined Prostate Cancer in Taiwan
2003
THE ROLE OF BCL-2, p53, AND KI-67 INDEX IN PREDICTING TUMOR RECURRENCE FOR LOW GRADE SUPERFICIAL TRANSITIONAL CELL BLADDER CARCINOMA
2000
Rankless by CCL
2026